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Many substituted imidazoles and triazoles are important antifungal agents for use in human and veterinary medicine and in the control of plant diseases. A number of effects of these compounds on intact cells, organelles, membranes and enzymes have been described as the basis of their antimycotic properties. In this overview some of these effects will be discussed.
Effects on cytochrome P-450
The imidazole and triazole derivatives investigated affect cytochrome P-450 in Saccharomyces cerevisiae microsomes (Van den Bossche & Willemsens, 1982; Van den Bossche et al., 1983) . Examples are imazalil. ketoconazole, miconazole, parconazole, propiconazole, terconazole and R 5 1 2 1 1. Addition of 55n~-ketoconazole to yeast microsomes caused a 50% decrease in the size of the peak at 450nm in the reduced CO spectrum of the cytochrome. Concentrations greater than 0.1 mM were needed to affect cytochrome P-450 in liver microsomes collected from normal Wistar rats (Van den Bossche et al., 1983) . This correlated with the high concentrations of miconazole and ketonazole needed to inhibit cholesterol synthesis in a subcellular fraction of rat liver as compared with ergosterol synthesis in similar fractions of S. cereuisiae or Candida albicans (Willemsens et al., 1980) .
Effects on sterol synthesis
Ergosterol biosynthesis in inhibited by all imidazole and triazole fungicides investigated so far. Examples are imazalil in Aspergillus nidulans, Botrytis cinerea, S . cerevisiae, Penicillium expansum, P. islandicum, P. italicum, Ustilago avenue and U. maydis and econazole, ketoconazole, miconazole, parconazole, terconzole and R 5 I 2 1 1 in C. albicans (Van den Bossche et al., 1983) . The inhibition coincided with an accumulation of the 14a-methylsterols lanosterol, 24-methylenedihydrolanosterol, 4,14-dimethylzymosterol, obtusifoliol and 14-meth ylfecosterol (Van den Bossche et al., 1978 . Recently a novel endogenous sterol metabolite, 14a-methylergosta-8,24(28)-diene-38.6a-di01, was found to accumulate under the influence of etaconazole added to U. maydis cultures (Ebert et al., 1983) .
Evidence is available for a detrimental effect of 14a-methylsterols on membranes and cells (Nes, 1974; Yeagle et al., 1977; Van den Bossche et al., 1983) .
Cholesterol synthesis in a subcellular fraction of rat liver is much less sensitive to these antifungal agents than is the ergosterol synthesis in, e.g. C. albicans and S . cereuisiae. This selectivity was further proven in uitro using intact fibroblasts and in uioo by using rats infected with C. albicans; 50% inhibition of cholesterol synthesis by fibroblasts was achieved after 24 h incubation in the presence of 0.7 pM-ketoconazole. Only 5 nM was needed to reach a similar inhibition of ergosterol synthesis in C. albicans after 24 h in Eagle's minimum essential medium (Heeres et al., 1981) . It is of interest that this concentration of ketoconazole inhibits ergosterol synthesis by 50% after only 1 h of contact (Van den Bossche et al., 1983) .
When ketoconazole was administered to rats, infected intravaginally with C. albicans, 50% inhibition of ergosterol synthesis in C. albicans was reached at 1.7rng/kg body wt. A 6-times higher dose was required to affect cholesterol synthesis in rat liver (Van den Bossche et al., 1980).
The azole derivatives investigated so far inhibit the 14a-demethylation reaction but do not interfere with the 4-demethylation of lanosterol, 4,14-dimethylzymosteroI or obtusifoliol. Evidence is available for the presence of cytochrome P-450 as a component of the 14-demethylase system and not of the 4-demethylase system (Gibbons et al., 1979; Aoyama & Yoshida, 1978a,b) . Based on this and on the observed selective effects on cytochrome P-450 and sterol biosynthesis, it is speculated that the inhibitory effects on the 14-demethylase system in yeast and fungal cells results from an interaction with the microsomal cytochrome P-450.
Effects on fatty acid synthesis
Ergosterol enables the yeast cells to grow optimally with a variety of unsaturated fatty acid sources (Buttke et al., 1980) . On the contrary lanosterol does not allow the cell sufficient flexibility to grow in the presence of a variety of fatty acids (Dahl et al., 1980) . Therefore, a decreased availability of ergosterol and the accumulation of 14-methylsterols in azoletreated Candida may also affect the flexibility to grow in the presence of different fatty acids. It is possible that the fungal cell may attempt to compensate for the alterations associated with sterol depletion. For example, sterol depletion of mouse LM cells defective in sterol biosynthesis results in specific changes in phosphatidylcholine by increases in oleate content and in the proportion of diunsaturated molecular species (Freter et al., 1979) . In this way these auxotrophs compensate for lowered sterol levels by providing lower melting membrane phospholipids whose 'fluidizing' effect would be normally provided by sterols (Freter et al., 1979) . In C. abicans. grown for 6 h in the presence of 0.1 PMketoconazole or miconazole, a shift occurred from mono-to di-unsaturated fatty acids in the phospholipids. The linoleate (C,,J content was found to be about 15% of the total amount of fatty acids in the phospholipid fraction of control cells and increased up to 22.5 and 25% in the phospholipid fraction of C. albicans incubated in the presence of ketoconazole or miconazole. This shift to more unsaturated fatty acids may reflect an attempt by the yeast cell to incresse membrane fluidity. Lauwers. unpublished work) .
The increased content of saturated fatty acids is indicative of an effect on the desaturase system. The latter, together with the accumulation of I4 methylsterols and decreased ergosterol content. may bc at the origin of thc azole derivative-induced effects on membrane properties and on membrane-bound enzymes. e.g. cytochrome oxidase. cytochrome peroxidase and NADH-dependent oxidase (De Nollin ef al., 1977; Borgers ef al.. 1977) . Further studies are planned to investigate the effects on the desaturase activity. The working hypothesis is that the accumulation of 14-methylsterols and the consequent altered fluidity of the membranes may cause a decreased activity of the membrane-bound desaturase.
Direct interaction with membrane lipids
A number of authors suggests that miconazole has a direct effect on mcmbranes resulting in a significant and almost immediate effect on membrane permeability of, e.g. C. albicans. erythrocytes and rat liver lysosomes (Sreedhara Swamy el a/.. 1974 . 1976a .h: Cope. 1980 . From this interaction, effects on mitochondrial activities and membrane-bound enzymes could be expected and are described (Dickinson. 1977; Foury et a/.. 1976; Dufour el a/.. 1980). All these changes were observed at concentrations > 5 p~ and most of them at concentrations > 1 0 ,~~. At 10-100p~. ketoconazole affects mitochondrial enzymes and causes direct membrane damage to C. albicans cells (Uno et al.. 1982 : Shigematsu et al.. 1982 . These effects may be related to a direct interaction of miconazole ( > I PM) and at higher doses of ketoconazole with lipid constituents of the membranes.
Using differential scanning calorimetry (Van den Bossche el al., 1982) it is shown that high concentrations of miconazole shift the lipid transition temperature of multilamellar vesicles, composed of (dipalmitoyl)phosphatidylcholine (dipalmitoyl glycerophosphocholine). t o lower values without affecting the enthalpy of melting. The miconazole-induced shift of the lipid transition temperature to lower values is suggestive of a change in lipid organization without binding to lipids.
In the presence of ketoconazole the pretransition vanishes but no significant shift of the main (dipalmitoy1)phosphatidylcholine transition temperature is observed at concentrations up to 30mol%. This indicates that, at the concentrations used. ketoconazole adopts in the lipid layer an orientation different from that of miconazole. Ketoconazole, being much less active than miconazole in affecting liposomes, also occupies in a lipid layer a much smaller area (3nm2) per drug molecule than miconazole (9nm2) (Brasseur el al., 1983) . As compared with ketoconazole. miconazole (0. I mM) also caused a more rapid release of marker [I4C ]glucose from liposomes composed of egg phosphatidylcholine and cholesterol. Furthermore, the membrane-bound cytochrome oxidase and ATPase activities in subcellular fractions of baker's yeast are more sensitive to miconazole ( 1 0 ,~~) than to ketoconazole (0.1 mM) (Van den Bossche et a/., 1982).
All these studies indicate that a direct alteration of the fluidity characteristics by an azole-derivative-induced change in lipid organization may be part of the antifungal property of miconazole, and much less of ketoconazole. However, all these effects are observed at high drug concentrations as compared with the concentrations needed to affect cytochrome P-450. sterol synthesis and fatty acid desaturation in yeast cells. Therefore, it is hypothesized that the direct interaction plays only a minor role in the antimycotic properties of these azole derivatives.
Working hypothesis
The interaction of azole derivatives with cytochrome P-450 is at the origin of the inhibition of ergosterol biosynthesis. with consequent accumulation of 14-methylsterols and altered fluidity of the membranes. This causes a decreased activity of the membrane-bound desaturase, resulting in an increased content of saturated fatty acids. The presence of 14-methylsterols and saturated fatty acids not only disturbs membrane permeability but also affects the activity of membrane-bound enzymes. Therefore, the interaction with cytochrome P-450 may be the basis of the antifungal properties of the azole derivatives.
